BioRestorative Therapies Announces Notice of Allowance on Key Patent for its BRTX-100® Disc Program
16 févr. 2022 08h30 HE
|
BioRestorative Therapies, Inc
Notice of Allowance Grants Protection for BioRestorative’s Phase 2 Clinical Program to Treat Chronic Lumbar Disc Disease MELVILLE, N.Y., Feb. 16, 2022 (GLOBE NEWSWIRE) -- BioRestorative Therapies,...
BioRestorative Therapies Announces Filing of Ten Patent Applications Related to its BRTX-100 Program
02 déc. 2021 06h00 HE
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Dec. 02, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company" or “BioRestorative”) (NASDAQ:BRTX), a life sciences company focused on adult stem cell-based...
BioRestorative Therapies Announces Nomination of Two New Members to the Board of Directors
26 oct. 2021 08h00 HE
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Oct. 26, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...